CAS NO: | 168482-23-3 |
包装 | 价格(元) |
1mg | 电议 |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
生物活性 | SHU 9119 is a potent human melanocortin 3 and 4 receptors (MC3/4R) antagonist and a partialMC5Ragonist; withIC50values of 0.23, 0.06, and 0.09 nM for humanMC3R,MC4RandMC5R, respectively. | ||||||||||||||||
IC50& Target |
| ||||||||||||||||
体内研究 (In Vivo) | Blockade of CNS-Mcr via chronic intracerebroventricular infusion of SHU9119 (24 nmol/d for 7 days) increases food intake in ad libitum-fed rats compared with control. Weight gain of SHU9119 treated rats is significantly higher than control. SHU9119 treatment potently increases metabolic efficiency. SHU9119 markedly increases mRNA levels of genes promoting lipogenesis and TAG storage in adipocytes, including stearoyl-CoA desaturase-1, lipoprotein lipase, acetyl-CoA carboxylase α, and fatty acid synthase[2]. SHU9119 increases food intake (+30%) and body fat (+50%) and decreases EE by reduction in fat oxidation (–42%). In addition, SHU9119 impairs the uptake of VLDL-TG by BAT. In line with this, SHU9119 decreases uncoupling protein-1 levels in BAT (–60%) and induces large intracellular lipid droplets, indicative of severely disturbed BAT activity[3]. | ||||||||||||||||
分子量 | 1074.24 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C54H71N15O9 | ||||||||||||||||
CAS 号 | 168482-23-3 | ||||||||||||||||
Sequence | Ac-{Nle}-cyclo[Asp-His-D-{Nal}-Arg-Trp-Lys]-NH2 | ||||||||||||||||
Sequence Shortening | Ac-{Nle}-cyclo[DHD-{Nal}-RWK]-NH2 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | Sealed storage, away from moisture and light
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) | ||||||||||||||||
溶解性数据 | In Vitro: H2O : 10 mg/mL(9.31 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |